Cure8 news brief
Cure8 news brief
Smoking and similar nicotine-product use after Crohn's surgery appears linked to higher rates of endoscopic recurrence, which may affect postoperative monitoring and secondary-prevention strategies. Patients using HNBT or e-cigarettes may need similar counseling and follow-up as traditional smokers.
Adults with Crohn's disease who are current smokers, e-cigarette users, or HNBT users; gastroenterologists and colorectal surgeons managing postoperative Crohn's patients; clinicians advising on smoking cessation and postoperative prophylaxis.
The study found higher endoscopic recurrence rates at 1 year among conventional smokers, HNBT users, and e-cigarette users versus nonsmokers, with HNBT showing a robust association after adjustment. Fecal calprotectin and modified Rutgeerts score analyses showed similar trends and the association persisted in patients receiving prophylactic medical therapy.
Who should discuss this with their care team: people with Crohn's disease who smoke or use HNBT/e-cigarettes, clinicians managing postoperative Crohn's patients, and caregivers involved in postoperative smoking cessation planning.
This classification is based on a news summary of a retrospective study published in the American Journal of Gastroenterology. Retrospective design can show associations but not prove causation; the e-cigarette association was not statistically significant after adjustment. The article summarizes the study findings but does not provide full trial data or long-term outcomes.
SummaryConfidence":"medium"
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.